REQUEST A DEMO
Total
USD $0.00
Search more companies

Artmed Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Artmed Sp. z o.o. Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Artmed Sp. z o.o. is based in Poland, with the head office in Zabrze. It operates in the Ambulatory Health Care Services industry. It was first established on May 12, 2004. Artmed Sp. z o.o. currently employs 39 (2006) people. In 2025, the company reported a net sales revenue increase of 5.47%. Its’ total assets recorded a negative growth of 45.68%. The net profit margin of Artmed Sp. z o.o. decreased by 2.53% in 2025.

Headquarters
Ul. Sienkiewicza 28
Zabrze; Slaskie; Postal Code: 41-800

Contact Details: Purchase the Artmed Sp. z o.o. report to view the information.

Website: http://www.rynekmedyczny.pl

Basic Information
Total Employees:
Purchase the Artmed Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Artmed Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Artmed Sp. z o.o. report to view the information.
Incorporation Date:
May 12, 2004
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Artmed Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
5.47%▲
Total Operating Revenue
5.47%▲
Net Profit/Loss for the Period
-39.55%▼
Total Assets
-45.68%▼
Total Equity
24.55%▲
Net Profit Margin
-2.53%▼
Return on Equity (ROE)
-16.94%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?